Trial Profile
A Randomized, Placebo-controlled Phase II b(OEV 123) Study to Evaluate Safety, Immunogenicity, Diagnostic Methodology, and Estimate Vaccine Efficacy of an Oral Enterotoxigenic Escherichia Coli(ETEC) Vaccine(ETVAX) for Prevention of Clinically Significant ETEC Diarrhea in Healthy Adult Travelers Visiting West Africa
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Traveller's diarrhoea vaccine (Primary)
- Indications Traveller's diarrhoea
- Focus Adverse reactions; Diagnostic use; Pharmacodynamics
- Sponsors Scandinavian Biopharma
- 06 Nov 2019 Status changed from active, no longer recruiting to completed.
- 10 May 2019 This trial is completed in Finland,according to European Clinical Trials Database record.
- 18 Mar 2019 Status changed from recruiting to active, no longer recruiting.